COGT   $9.13  1.67% Market Closed After Close 9.01 -1.31%

Cogent Biosciences Inc
Total Cash 363.22M
totalCashPerShare 3.319
EBITDA -242.22M
Total Debt 18.18M
quickRatio 9.08
currentRatio 9.249
Total Revenue
debtToEquity 4.872
Revenue/Share
ROA -0.37182
ROE -0.62924
grossProfits
freeCashflow -100.41M
operatingCashflow -177.27M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 862.50M
forwardPE -4.5565214
floatShares 70.23M
sharesOutstanding 109.45M
sharesShort 8.58M
sharesShortPriorMonth 9.73M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.12%
Short Ratio help_outline 9.54%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 2.37
Price To Book help_outline 4.42
earningsQuarterlyGrowth
netIncomeToCommon -227.04M
trailingEps -2.49%
forwardEps -2.30%
enterpriseToEbitda -3.56
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.57 3Q 2024
institutionsCount 210
lastUpdated Nov. 7, 2024, 3:26 a.m.